Log in

LON:HCM - Hutchison China MediTech Share Price, Forecast & News

GBX 398
-22.00 (-5.24 %)
(As of 02/23/2020 03:23 AM ET)
Today's Range
Now: GBX 398
50-Day Range
MA: GBX 407.16
52-Week Range
Now: GBX 398
Volume20,766 shs
Average Volume13,897 shs
Market Capitalization£2.75 billion
P/E RatioN/A
Dividend YieldN/A
Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major



Sales & Book Value

Annual Sales£204.65 million
Cash FlowGBX 28.03 per share
Book ValueGBX 47.10 per share



Market Cap£2.75 billion
Next Earnings Date3/3/2020 (Estimated)
OptionableNot Optionable

Receive HCM News and Ratings via Email

Sign-up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

Hutchison China MediTech (LON:HCM) Frequently Asked Questions

What is Hutchison China MediTech's stock symbol?

Hutchison China MediTech trades on the London Stock Exchange (LON) under the ticker symbol "HCM."

When is Hutchison China MediTech's next earnings date?

Hutchison China MediTech is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Hutchison China MediTech.

What price target have analysts set for HCM?

2 Wall Street analysts have issued 12 month target prices for Hutchison China MediTech's stock. Their forecasts range from GBX 360 to GBX 5,940. On average, they anticipate Hutchison China MediTech's stock price to reach GBX 3,150 in the next twelve months. This suggests a possible upside of 691.5% from the stock's current price. View Analyst Price Targets for Hutchison China MediTech.

What is the consensus analysts' recommendation for Hutchison China MediTech?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hutchison China MediTech in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hutchison China MediTech.

Has Hutchison China MediTech been receiving favorable news coverage?

News headlines about HCM stock have trended very negative recently, InfoTrie reports. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hutchison China MediTech earned a news impact score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Hutchison China MediTech.

Who are some of Hutchison China MediTech's key competitors?

What other stocks do shareholders of Hutchison China MediTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hutchison China MediTech investors own include Intelsat (I), Associated British Foods (ABF), Fossil Group (FOSL), Chaarat Gold (CGH), AMC Entertainment (AMC), Bank of America (BAC), First Data (FDC), Air Canada (AC), tronc (TRNC) and Apollo Global Management (APO).

Who are Hutchison China MediTech's key executives?

Hutchison China MediTech's management team includes the folowing people:
  • Mr. Chi Keung To B.Sc., M.B.A., BSc, ACGI, MBA, Exec. Chairman (Age 67)
  • Mr. Christian Hogg B.Sc., M.B.A., BSc, MBA, CEO & Exec. Director (Age 53)
  • Mr. Johnny Cheng C.A., BEc, CA, CFO & Exec. Director (Age 52)
  • Dr. Weiguo Su B.Sc., Ph.D., Chief Scientific Officer, Exec. VP & Exec. Director (Age 62)
  • Ms. Edith Shih B.S., M.A., BSE, MA, EdM, Solicitor, FCIS, FCS(PE), Company Sec. & Non-Exec. Director (Age 67)

How do I buy shares of Hutchison China MediTech?

Shares of HCM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Hutchison China MediTech's stock price today?

One share of HCM stock can currently be purchased for approximately GBX 398.

How big of a company is Hutchison China MediTech?

Hutchison China MediTech has a market capitalization of £2.75 billion and generates £204.65 million in revenue each year. Hutchison China MediTech employs 714 workers across the globe.View Additional Information About Hutchison China MediTech.

What is Hutchison China MediTech's official website?

The official website for Hutchison China MediTech is http://www.chi-med.com/.

How can I contact Hutchison China MediTech?

The company can be reached via phone at +85221213888.

MarketBeat Community Rating for Hutchison China MediTech (LON HCM)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  193 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  299
MarketBeat's community ratings are surveys of what our community members think about Hutchison China MediTech and other stocks. Vote "Outperform" if you believe HCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel